chrisvoncsefalvay/vaers-outcomes huggingface dataset:
hot to touch at site of vaccination; Covid arm - rash; Itchiness; redness; Swelling; This is a spontaneous report from a non-contactable consumer (patient).   A non-pregnant 36-year-old female patient received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: ep7534) via an unspecified route of administration, administered in arm on 25Mar2021 (at the age of 36 years old) as dose number unknown, single for COVID-19 immunisation. Medical history was not reported. Concomitant medication included iron. Patient had no other vaccine in four weeks and no other medications in two weeks. Patient had no COVID prior vaccination and not COVID tested post vaccination. On 01Apr2021, the patient experienced hot to touch at site of vaccination, rash, itchiness, redness, and swelling (8 days after the first dose, as reported). The outcome of the events was not recovered.   No follow up attempts are possible. No further information is expected.
No additional AE; Patient was inadvertently administered PROQUAD on 1/18/2022 at the age of 14.; This spontaneous report was received from a medical assistant referring to a 14 years old patient of unknown gender. Concomitant medication, pertinent medical history and drug reactions/allergies were not reported.   On 07-DEC-2020, the patient received a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (strength, route, lot# and expiration date were not reported) for prophylaxis at another clinic.   On 18-JAN-2022, at the age of 14 years old, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin (rHA)) (PROQUAD) (strength and route were not reported; 0.5 ml, lot # U002530, expiration date: 24-JUL-2022) for prophylaxis (product administered to patient of inappropriate age).         No additional adverse event was reported.
Patient was given Yellow Fever vaccine on 15Oct05. Patient states the next day she started feeling sick. By Monday she states she was having itching, redness, and warm to touch at vaccine site.
Skin peeling; Eczema; Fatigue; Swollen lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of SKIN EXFOLIATION (Skin peeling), ECZEMA (Eczema), FATIGUE (Fatigue) and LYMPHADENOPATHY (Swollen lymph nodes) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Crohn's disease.    Concurrent medical conditions included Crohn's disease.   In September 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In September 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 1 dosage form. In September 2021, the patient experienced ECZEMA (Eczema), FATIGUE (Fatigue) and LYMPHADENOPATHY (Swollen lymph nodes). On an unknown date, the patient experienced SKIN EXFOLIATION (Skin peeling). At the time of the report, SKIN EXFOLIATION (Skin peeling), ECZEMA (Eczema), FATIGUE (Fatigue) and LYMPHADENOPATHY (Swollen lymph nodes) outcome was unknown.            This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  The concomitant medication was not reported.  The reporter causality for the events with respect to Humira was reported as not reported.   The treatment medication was not provided.
2 days after 2nd dose, experienced sever, intense cramps, and profuse menstrual bleeding. only one week after my normal cycle had stopped. day 1 was unusually heavy, day 2 was extremely heavy the whole day and night.  days 3 and 4 and 5 were heavy, but not as painful. the bleeding seems to have finally subsided now, day 9. my normal cycle usually only lasts a few days and is very light, rarely painful or with cramping.
99.9-102.5 fever for 3 days, giant red swollen hot spot at the injection site that lasted a week, painful joints so bad that I couldn't close my hands to make a fist, extreme nausea, rapid heartbeat, severe facial swelling that started on day 5, and still have severe facial swelling on day 16.
This spontaneous report as received from a Doctor of Pharmacy refers to an unspecified number of patients of unknown age and gender. No medical history or drug reactions/allergies were provided. On an unknown date, the patients were vaccinated with ZOSTAVAX (lot# and dose not provided), subcutaneously in the back of the arm, instead of the deltoid. No adverse symptoms were reported. Additional information has been requested.
Induration at site of injection, warm to touch, slightly swollen. Treated with ice applied to area.
Dose 1 - extremely sore arm for 1 week, nausea, fatigue Dose 2 - extremely sore arm and COVID arm rash appearing 2 days later, headache, fatigue
Area where injected became red, swollen and warm to touch, arm achy. Instructed to use warm compress and call tomorrow if no better. Mom gave BENADRYL once week.
Pale, cool, clammy, N/V, dizzy and felt as if she was about to faint.
When taking immunizations out of refrigerator nurse  took out the wrong medication Bexsero.  Patient should have been given Menactra.
Use by date was 5/12/22 and vaccine was administered on 5/18/22.
13 year old female previously healthy, no chronic diseases,.10 days after the 1st dose of Pfizer COVID19 vaccine, she developed fatigue, lethargy, paleness and dizziness. She was found to be profoundly anemic and was diagnosed with autoimmune hemolytic anemia; she was also found to have positive high-titer (1:1280) antinuclear antibody (ANA) testing (status prior to vaccination unknown). She was diagnosed with mixed cold/warm autoimmune hemolytic anemia. She received two units of packed red blood cells via blood transfusion and was treated with high-dose corticosteroids (both IV and oral). The anemia has resolved but the patient remains on oral corticosteroids (prednisone).
Within 24 hours of Pfizer injection, left armpit lymph node was swollen and incredibly painful both on the gland and on the breast area.  On the direct location of the injection, a large patch of redness filled the area.  Within 48 hours, the clavicle gland was also swollen with pain in the groin area combined with dizziness and lightheadedness . Due to the swelling, there was a radiation into the nerves of the left hand & tingling  (on the side of the vaccination site) and the same experienced down the left leg.  96 hours later and the lymph node swelling has reduced but is still present.  At the vaccination site, the area is itchy and flaking.
Mild to moderate SOB with dry cough and headache beginning 10-28-21. PCR Covid nasal test taken 11-3-21 with Positive results on 11-4-21. Ordered Steroids and Inhalation treatments per PCP. Received Monoclonal Antibody treatment 11-5-21 with some improvement of shortness of breath and cough. Continued with mild to moderate SOB and cough with headache and fatigue for 2 months. Symptoms worsened January 2, 2022 and was seen in Urgent Care and then Emergency Rm. Antibiotics initiated. PCP ordered CT scan. Started on Decadron and different Antibiotics. Currently still having mild SOB with cough and headache.
This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received PREVNAR 13, (Lot number and Expiration date: Unknown), via an unspecified route of administration at the arm on 23Oct2018 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date after receiving PREVNAR 13 the patient had reaction. The patient's was arm swollen, red and developed lump at site. The doctor recommended to ice it and take BENADRYL and recommended steroid shot. The patient declined the steroid shot. The outcome of the events was not reported. Information on the lot number has been requested.
Swelling, soreness & fever at injection site. Began on 2/15/12, worsened on 2/16 & 2/17.
This spontaneous report received from a nurse (R.N.) refers to a 3 month old male patient. On 27-MAY-2013 the patient was vaccinated with a dose of PEDVAXHIB (lot # reported as 1531AA, exp. date 20-MAR-2013) (dose, route, injection site and indication not provided). On 17-MAY-2013, the patient administration of an expired dose of PEDVAXHIB. The outcome of the event was unknown. Additional information has been requested.
Patient came into health department for immunizations prior to school. Patient expressed being anxious about shots. Three immunizations were given. Following immunizations patient vomited passed out and had a very brief seizure. Patient woke up immediately alert and oriented. No shortness of breath, redness or itching observed, vital signs were normal. Patient observed for 60 min after incident no further adverse events observed. Patient was referred to his PCP at clinic for follow up.
LEFT DELTOID -MOTHER NOTED LEFT DELTOID AREA WAS SWOLLEN, RED,"HOT TO TOUCH" & HARD" @ 6PM MOTHER APPLIED "TRIAXOLONE" & WHEN CHILD WAS NOTED ITCHING MOTHER APPLIED ALCOHOL.  SWELLONG CONSIDERABLY RESOLVED, THIS AM, PER MOTHER
pericarditis Narrative: after #2 dose of covid vaccine seen at hospital  Ed for pericarditis, then discharged to home  Other Relevant History:
This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for Covid), HEAD DISCOMFORT (Congested in her head), MYALGIA (She has some arm and body ache) and EXPOSURE DURING PREGNANCY (pregnant and took the vaccine while pregnant) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 30A21A) for COVID-19 vaccination. Concurrent medical conditions included Thyroid disorder NOS. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder NOS. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 05-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (pregnant and took the vaccine while pregnant). On 12-Jul-2021, the patient experienced COVID-19 (tested positive for Covid). On an unknown date, the patient experienced HEAD DISCOMFORT (Congested in her head) and MYALGIA (She has some arm and body ache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 02-Apr-2021, EXPOSURE DURING PREGNANCY (pregnant and took the vaccine while pregnant) had resolved. At the time of the report, COVID-19 (tested positive for Covid), HEAD DISCOMFORT (Congested in her head) and MYALGIA (She has some arm and body ache) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Jul-2021, SARS-CoV-2 test: positive (Positive) positive. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. This case was linked to MOD-2021-255612 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 18-Jul-2021: Follow-up information received on 18-JUL-2021 contains no new information.
day 1 ?..12 hours following vaccination. chills. within 30 minuteslater, vomiting. The vomiting continued for 6 hours until I took Pepto Bismol. Fatigue followed with aches and pains from vomiting all night. Day 2....Slept the entire day was dehydrated and drank Pedi light no appetite had I slice of bread. Day 3 began to feel better with mild diarrhea, still experiencing aches and pains in chest and ribs from the results of the horrific vomiting. Day 4.. Feeling better than day 3 with still mild diarrhea and less aches and pains. could actually cough without feeling my lungs may implode. day 5 back to work still mild gastrointestinal issues. definitely on the mend
Approximately after receiving the first dose of COVID-19 vaccine, a 24-year old female patient experienced an episode of syncope/near-syncope. She was immediately assisted by a pharmacist onsite, who helped the patient to lie on the ground with her legs elevated.  The patient immediately regained consciousness and was speaking normally. The patient was monitored closely for approximately 45 minutes. At that time, the patient reported feeling no symptoms or side effects, and was allowed to leave with instructions to seek appropriate medical attention if needed for further symptoms.
This case was reported in a literature article and described the occurrence of epiglottitis in a 16-year-old male subject who was vaccinated with Haemophilus influenzae type b vaccine (manufacturer unspecified). On an unspecified date, the subject received unspecified dose of Haemophilus influenzae type b vaccine (unknown route, site of injection and batch number). At an unspecified time after vaccination, with Haemophilus influenzae type b vaccine, the subject experienced, fever, sore throat, dysphagia and dyspnea, which was diagnosed as epiglottitis. The subject was admitted and brought to the operating room for controlled intubation. A deep plane of anesthesia was obtained via inhalational anesthesia (end tidal sevoflurane) with the subject breathing spontaneously in a sitting position. Direct laryngoscopy revealed grade IV view secondary to an edematous epiglottis. The airway was secured with a 6.5-mm endotracheal tube, by use of a Parsons laryngoscope. The subject was treated with antibiotics for 24 h. He was extubated and discharged.
Minor limp node swelling; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Minor limp node swelling) and NAUSEA (Nausea) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Minor limp node swelling) and NAUSEA (Nausea). At the time of the report, LYMPHADENOPATHY (Minor limp node swelling) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medications were unknown.
This spontaneous report was received from a physician via company representative referring to a male patient of unknown age. The patient's concurrent conditions, medical history and concomitant medications were not provided. On unknown dates, the patient was vaccinated with the first and second doses of ROTATEQ dose 1, (strength, dose,  frequency, indication, lot# and expiration date were not provided) for prophylaxis. The physiscian reported that the patient received his first 2 doses of ROTATEQ via gastric tube (g-tube). No adverse symptoms were reported and no product quality complains was reported. No further information provided.
2003: Patient walking in hallway immediately after receiving vaccines and fell onto a chair - no signs of injury; took patient to lie down on a bench & placed ice cold compresses on anterior and posterior neck as well as forehead; drank sips of water 2010: Patient sitting up, talking and sipping water; offered Peanut butter crackers and she ate w/o issues 2020: Patient denied complications and ambulated out of Facility with mom.
Two inch red circle with white center at injection site. Pain in the shoulder are radiating down the arm. Limited range of motion in shoulder and arm with incredible pain. Took Advil, iced area with no relief. At two weeks the redness, pain and range of motion are still there.
Left deltoid redness and swelling, warm to touch.  Symptoms developed 2 days after the injection.  Had no treatment such as cool compress or tylenol, saw MD on 12/10/03, diagnosed with local reaction, treated with Benadryl, tylenol.  Temp 98.4F
next day had leg pain and swelling on right side. over the next several days, significant bruising, swelling and pain
Generalized rash and puritis developed approximately 90 minutes after recieving a dose of FluMist.
Immediately after giving vaccine the patient turned gray, pale, and asked to lie down. Patient stated that her stomach hurt and she might vomit.  Laid patient down on the exam table.  Got water and ice pack and had patient rest for 5 minutes.  Stayed in room with patient and mother After 5 minutes patients color returned and she felt she could sit up.  Instantly after sitting up she felt sick again and lost color.  Laid patient down again.  Called for nurse.  Began taking Vitals .  Nurse came in to exam and spoke to patient and gave her apple juice. Nurse stayed in room with patient and mother.  Let patient rest for 10 minutes and then she sat up and stayed for another 5 minutes.  No injury to patient. Provider notified and patient rechecked/monitored. Patient observed and symptoms completely resolved. Flag added to chart that patient should be monitored after any vaccine or blood draw, all reporting completed.
nausea, fever , body aches, lethargy  but most concerning and still continuing is a pain in the heart area that is currently still ongoing.
The patient received a flu shot on Wed 9/16 and came back for the pneumonia vaccine since she can only have shots in one arm.  There were multiple needing flu shots & she was thought to need both that day so the flu was administered a second time on Thurs.  9/17 instead of the pneumonia.  There was no adverse reaction.
PT complained of sweaty palms and anxiety.  RN asked to remove mask and started breathing exercises.  PT stated she has been diagnosed with anxiety disorder and that she could not sleep the night before.  Vitals were monitored... 0939  120/78 0949  117/80  PT was held an additional 10 minutes after the 15 minute observation period then discharged to sister and recommended her to contact her primary doctor in case symptoms persist.
Tingling that is going  very quickly throughout her body, one spot to another spot/Pins and needles; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling that is going  very quickly throughout her body, one spot to another spot/Pins and needles) and MYALGIA (Soreness) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination.     The patient's past medical history included Lymphadenectomy (20 years ago). Concomitant products included COLESEVELAM HYDROCHLORIDE (WELCHOL) and EXEMESTANE for an unknown indication.    On 22-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (Tingling that is going  very quickly throughout her body, one spot to another spot/Pins and needles) and MYALGIA (Soreness). At the time of the report, PARAESTHESIA (Tingling that is going  very quickly throughout her body, one spot to another spot/Pins and needles) and MYALGIA (Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
This spontaneous report was received from a registered pharmacist and refers to a 63 year old patient of unknown gender. Information regarding pertinent medical history, drug reactions or allergies and concomitant therapy was not reported. On 06-JUL-2017, the patient was vaccinated with an improperly stored ZOSTAVAX, lot number M041087 with expiration date 03-JAN-2018 (dosage schedule, anatomical location and route of administration not provided) for prophylaxis, reconstituted with properly stored diluent (MRK INJ). The administered vaccine was exposed to a temperature of 6 degree Fahrenheit to 14 degree Fahrenheit for 1 hour. Previous temperature excursion was reported as 6 degree Fahrenheit to 14 degree Fahrenheit for 45 minutes. The call was because of a data logger. No adverse effects were reported. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1708USA010696: US-009507513-1708USA010732: US-009507513-1709USA014570: US-009507513-1709USA014571: US-009507513-1709USA014572: US-009507513-1709USA014573: US-009507513-1709USA014574: US-009507513-1709USA014575: US-009507513-1709USA014576: US-009507513-1709USA014577.
Moderna Bivalent Booster 0.25mcg was given to patient not the full dose 0.5mcg. Wrong dose given.
L leg from bottom of knee to L thigh swollen. No redness or c/o of pain. Child scratched leg upper, sleeping. No signs of onset hives or other marks. Not yet recovered, symptoms just appeared.
This case was reported by a consumer via call center representative and described the occurrence of swollen joints in a 64-year-old male patient who received SHINGRIX. On 4th May 2018, the patient received SHINGRIX. In May 2018, 3 days after receiving SHINGRIX, the patient experienced swollen joints, swollen thumb, neck swelling, injection site swelling and back pain. On an unknown date, the outcome of the swollen joints, swollen thumb, neck swelling and back pain were not recovered/not resolved and the outcome of the injection site swelling was recovered/resolved. The reporter considered the swollen joints, swollen thumb, neck swelling, injection site swelling and back pain to be possibly related to SHINGRIX. Additional details were provided as follows: The patient did not get any other vaccine on the vaccination day of SHINGRIX and said that he had been on long term medications for a long time and did not want to provide that information. The patient said the only new treatment was the SHINGRIX vaccine. The patient after about 3 to 4 days of receiving SHINGRIX vaccine started experiencing symptoms. The patient had the regular swelling at the injection site that went away immediately in May 2018. But, he also experienced swelling in all joints including knee, hips, thumbs and neck. The swelling was even getting worse. The patient was also having pain in his back. The physician details were provided.
Patient experienced immediate lip swelling after receiving first vaccine dose. Patient was given Benadryl 25 mg, oral, and observed for one hour after receiving COVID vaccine.
Pfizer 4/20/21, 5/11/21, 12/16/21. Positive on 7/12/22
Pt received vaccine at pharmacy, 2-3 days later, started with a rash along trigeminal dermatome; R sided; Now about 10 days out it is resolving.
Flu like symtoms: Achy all over especially mid back, sore arm at injection site.
Information has been received from a licensed practical nurse concerning a 4 year old female patient who on 29-MAR-2007 was vaccinated subcutaneously with a 0.5 mL dose of ProQuad (lot# 654474/0815F). Concomitant vaccination on the same day included a dose of Varivax (lot# 656567/1512F). The nurse reported that the office confused the ProQuad vaccine with MMR II in the freezer. Unspecified medical attention was sought. No problems were reported. A product quality complaint was not involved. The patient's twin sister had a similar experience after therapy with ProQuad (WAES # 0704USA01031). Additional information has been requested. This is one of several reports from the same source.